These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 12638474

  • 1. [New antiaggregants and their importance for the practitioner].
    Tsakiris DA.
    Ther Umsch; 2003 Jan; 60(1):24-6. PubMed ID: 12638474
    [Abstract] [Full Text] [Related]

  • 2. [Antithrombotic treatment of acute coronary syndromes without ST-segment elevation].
    Radke PW, Schunkert H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47 Suppl 7):S204-7. PubMed ID: 17109249
    [No Abstract] [Full Text] [Related]

  • 3. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T, Frere C, Quilici J, Morange PE, Mouret JP, Bali L, Moro PJ, Lambert M, Alessi MC, Bonnet JL.
    JACC Cardiovasc Interv; 2008 Dec 24; 1(6):649-53. PubMed ID: 19463379
    [Abstract] [Full Text] [Related]

  • 4. ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy.
    Boden WE, Hoekstra J, Miller CD.
    Am J Emerg Med; 2008 Feb 24; 26(2):212-20. PubMed ID: 18272105
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.
    Hobbach HP, Schuster P.
    Z Kardiol; 2003 Mar 24; 92(3):213-8. PubMed ID: 12658467
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G, Sciagrà R, Migliorini A, Memisha G, Moschi G, Valenti R, Pupi A, Antoniucci D.
    Am Heart J; 2005 Aug 24; 150(2):220. PubMed ID: 16086921
    [Abstract] [Full Text] [Related]

  • 7. Aspirin in patients with coronary artery disease: is it simply irresistible?
    Nair GV, Davis CJ, McKenzie ME, Lowry DR, Serebruany VL.
    J Thromb Thrombolysis; 2001 Apr 24; 11(2):117-26. PubMed ID: 11406726
    [No Abstract] [Full Text] [Related]

  • 8. [New antiplatelet agents].
    Diez-Ewald.
    Invest Clin; 2000 Sep 24; 41(3):147-8. PubMed ID: 11029831
    [No Abstract] [Full Text] [Related]

  • 9. Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.
    Gibson CM, Moynihan JL, Al-Mousa EN, Campsey M, Gandhi R, Murphy S, Mattson S, Ryan KA, Mesley R, Swanson J, Arshad MN, Marble SJ.
    J Thromb Thrombolysis; 1999 Jun 24; 7(3):287-302. PubMed ID: 10375390
    [No Abstract] [Full Text] [Related]

  • 10. What have We learned from ESPRIT? What will we learn from TARGET?
    Ferguson JJ.
    J Invasive Cardiol; 2000 Jun 24; 12(6):317-9. PubMed ID: 10859719
    [No Abstract] [Full Text] [Related]

  • 11. Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.
    Mukherjee D, Chew DP, Robbins M, Yadav JS, Raymond RE, Moliterno DJ.
    J Thromb Thrombolysis; 2001 Apr 24; 11(2):151-4. PubMed ID: 11406730
    [Abstract] [Full Text] [Related]

  • 12. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
    Ferguson JJ, Antman EM, Bates ER, Cohen M, Every NR, Harrington RA, Pepine CJ, Theroux P, NICE-3 Investigators.
    Am Heart J; 2003 Oct 24; 146(4):628-34. PubMed ID: 14564315
    [Abstract] [Full Text] [Related]

  • 13. [Clinical use of glycoprotein IIb/IIIa inhibitors].
    Simonetti I, Gallopin M, Gensini GF.
    Ann Ital Med Int; 1998 Oct 24; 13(3):163-8. PubMed ID: 9859573
    [Abstract] [Full Text] [Related]

  • 14. [Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].
    Auer J, Berent R, Maurer E, Mayr H, Weber T, Eber B.
    Herz; 2001 Mar 24; 26(2):99-110. PubMed ID: 11349620
    [Abstract] [Full Text] [Related]

  • 15. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
    Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
    Circulation; 2002 Oct 01; 106(14):1893-900. PubMed ID: 12356647
    [No Abstract] [Full Text] [Related]

  • 16. Antiplatelet therapy for ischemic heart disease.
    Lange RA, Hillis LD.
    N Engl J Med; 2004 Jan 15; 350(3):277-80. PubMed ID: 14724308
    [No Abstract] [Full Text] [Related]

  • 17. New antiplatelet agents.
    White HD, French JK, Ellis CJ.
    Aust N Z J Med; 1998 Aug 15; 28(4):558-64. PubMed ID: 9777140
    [Abstract] [Full Text] [Related]

  • 18. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M, Ruf A, Neumann FJ, Pogátsa-Murray G, Dickfeld T, Zohlnhöfer D, Schömig A.
    Thromb Haemost; 1998 Dec 15; 80(6):994-1001. PubMed ID: 9869173
    [Abstract] [Full Text] [Related]

  • 19. Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
    Leopold JA, Antman EM.
    Circulation; 2005 Mar 08; 111(9):1097-9. PubMed ID: 15753225
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
    Brener SJ, Moliterno DJ, Lincoff AM, Steinhubl SR, Wolski KE, Topol EJ.
    Circulation; 2004 Aug 24; 110(8):994-8. PubMed ID: 15302778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.